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Abstract 
We investigated the potential of gelatin microspheres (GMs) loaded with platelet-rich plasma (PRP) to 
enhance their wound healing effect. Platelets from the PRP were immobilized onto GMs to form 
biomimetic bioreactor GM+PRP. The therapeutic effect of this agent was further investigated in vivo on a 
wound-healing model in rats. Wounds were locally injected with phosphate buffered saline (PBS), GM, 
PRP, and GM+PRP. Wound healing rate, vessel density, and inflammation level were measured 
histologically, by RT-PCR, and by Western blotting at days 3, 7, 14, and 21. Platelets on GM caused a 
continuous high release in both interleukin-10 and metalloproteinase-3 compared with PRP alone. Both 
GM+PRP and PRP successfully accelerated the wound healing process, while GM alone did not improve 
the wound healing process compared with the untreated control. Wounds treated with GM+PRP 
resulted in shorter healing period and improved dermal structure. GM+PRP improved angiogenesis in the 
wound by increasing expression of angiogenic factors. GM+PRP prolonged and enhanced the cytokine 
release profile compared with PRP. By promoting the inflammatory and angiogenic responses, GM+PRP 
has the potential to improve wound healing. Our findings demonstrate that GMs are an injectable carrier 
that enhanced the therapeutic effects of PRP. 
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Introduction 
Wound healing, including inflammation, 
proliferation and remodeling, is a dynamic process 
[1]. Chronic diseases and aging can interrupt the 
wound healing process, even though patient 
morbidity and the risk of infection may be lowered 
due to early wound closure [2, 3]. This disruption may 
cause chronic wound and hypertrophic scar 
formation, which can complicate treatment. 
Advances in tissue engineering and regenerative 
medicine, like tissue-engineered skin substitutes, have 
brought numerous benefits [4]. However, 
tissue-engineered skin substitutes have their own 
limitations. Culturing autologous skin substitute 
takes time, and transplanting allogeneic skin 
substitute runs the risk of immune rejection. 
Platelet-rich plasma (PRP) belongs to the plasma 
component and has high concentration in rich platelet 
compared with baseline [5, 6]. Chemokines, cytokines, 
matrix proteins, and growth factors are abundantly 
found in PRP [7-9]. PRP is usually prepared 
spontaneously from blood plasma to heal chronic and 
acute wounds [10-13]. Especially in the treatment of 
ulcerative diseases, the healing effect of PRP is more 








epidermal growth factor (EGF), platelet-derived 
growth factor (PDGF), transforming growth factor-β 
(TGF-β), and vascular endothelial growth factor 
(VEGF) bring about beneficial effects on wound 
healing [14-16]. Therefore, research on PRP 
regeneration has attracted extensive attention in the 
fields of regenerative medicine and tissue 
engineering. At present, the application of PRP in 
clinical science involves many fields, such as 
orthopedics, dentistry and ophthalmology [17]. The 
clinical effectiveness of non-activated autologous 
platelet-rich plasma (A-PRP) and activated 
autologous platelet-rich plasma (AA-PRP) for the 
treatment of Androgenic alopecia (AGA) and pattern 
hair loss had been demonstrated in recent reports 
[18-21], which had confirmed that A-PRP and 
AA-PRP had significant efficacy and no side effects 
[22, 23]. In orthopedics, PRP is injected into patients 
with knee arthritis to relieve pain and promote the 
proliferation of human synovium and chondrocytes 
[24]. The use of PRP after tooth extraction can 
accelerate wound and cartilage tissue healing. 
Treatment of dormant corneal ulcers, soft tissue 
defects, and hidradenitis suppurativa with PRP has 
shown positive outcomes [18, 25]. 
Despite the potential benefits of PRP in wound 
healing, currently it is limited by its low localized 
growth factors concentration, short half-life, and lack 
of standardized preparation methods [22, 26, 27]. The 
growth factors in PRP need to be secreted in 10 min 
but most growth factors are secreted in 1 h; therefore, 
the growth factors are diluted and rapidly 
decomposed into the bloodstream after injection. The 
concentrations of secreted growth factors and the 
platelet amount are linearly proportional. To address 
the aforesaid concerns, a biocompatible material was 
used to a set up a controlled system [28]. Due to the 
similarity in components and structure, gelatin is a 
good implantable material in the clinic [23, 26, 28]. 
The use of gelatin as a carrier of PRP retains growth 
factors at the application site, thus accelerating 
angiogenesis and wound healing [29-32]. Gelatin 
plays an important role in wound treatment [18] and 
preservation of PRP [33]. Research on gelatin 
microspheres (GMs) involves many fields such as 
biology, medicine, and chemistry. Recently, growth 
factors have been carried in GMs to be delivered. 
Compared with other forms of carriers, the 
advantages of microspheres are that they can extend 
the h55alf-life of growth factors that they carry [34], 
and consequently improve the therapeutic effect in 
vivo [22, 35]. GMs loading PRP has been applied for 
tissue regeneration, such as treatment in the 
osteoarthritis in rabbit [36], treatment for the 
degenerated intervertebral disc (IVD) model in rabbit 
[37, 38], bone regeneration in rabbit [39, 40], and 
treatment of ischaemic disorders in mouse [41]. 
The aim of this study is to use GMs as a carrier to 
improve the effects of PRP on the process of wound 
healing. We examined the growth factor released 
from the biomimetic bioreactor compound 
(GM+PRP), and measured cell proliferation. Then, we 
injected the novel compounds into a rat wound 
model. Finally, we assessed wound healing rate, 
angiogenesis, and the inflammation level with 
biochemical and histological analysis to investigate 
the efficacy in treating full thickness wound. 
Material and methods 
Preparation of GMs 
To prepare GMs, 1-ethyl-3-dimethylamino-
propyl carbodiimide hydrochloride (EDC) as used for 
crosslinking gelatin in an emulsion state [42]. At first, 
gelatin was dissolved in deionized water to give 10 
wt% gelatin solution, which was then used to dissolve 
type A gelatin with isoelectric point of 5 (Ward’s 
Science, NY, USA) in a hot-water bath. 
Next, paraffin (50 mL, containing span 80 [1%, 
TCI, OR, USA]) was added dropwise to the 10 mL 
solution. Magnetic stirring was used to emulsify the 
mixture for 20 min. The lactescent mixture was then 
put on an ice bath to quickly cool, then the gelatin was 
gently stirred in cold solution for washing. 
Subsequently, the aqueous solution of gelatin was 
added to cold acetone (50 mL, 4 °C), and was 
centrifuged (4 °C, 1000 rpm) to collect GMs. Then, the 
remaining paraffin on the surface was removed by 
washing the microspheres in chilled acetone for three 
times, and then in evaporated acetone in a baking box. 
To crosslink the GMs overnight, the microspheres (1 
g) with EDC (50 mM, ProteoChem, IL, USA) and 
DW/acetone (1:4, v/v) were added into a 50 mL 
container and then the mixture was stirred by 
magnetic stirring on low speed. For freeze-drying, the 
microspheres were rinsed three times in DW. The 
release profiles of IL-10 and TIMP-3 in the GM+PRP, 
GM, and PRP groups were assessed by ELISA. Upon 
being in contact with the activator, the growth factors 
were abruptly and immediately secreted by PRP, and 
were rapidly dispersed into the surroundings. 
PRP preparation and adhesion 
Adult rats (weighed about 425 ± 25 g, n=3) 
received pentobarbital (dose 65 mg/kg body weight) 
administration by intraperitoneal injection. The tubes 
were added with 10% sodium citrate (0.5 ml) as 
anticoagulant to deposit the blood specimen (5 mL) 
that was extracted from the abdominal aorta. Then the 
specimen was centrifuged (10 min, 2516 g. To 
precipitate the platelets, plasma was collected and 




centrifuged (1000 g for 10 min). Then, PRP was 
obtained by suspending the precipitated platelets in 
the platelet-poor supernatant. To immobilize the PRPs 
onto the GMs, we added PRP solution (0.5 ml) 
carefully to the GM+PRP (50 mg) mixture and then 
placed the mixture in a thermostat at 37 °C for 1 h. We 
rinsed off the unattached PRP from the microspheres 
using DW wash off. The GM+PRP and GMs were 
coated with gold, and were examined by scanning 
electron microscopy (SEM) (Hitachi S-3000N, Japan). 
The number of platelets were 612 × 104/µL (SD: 156 × 
104/µL) in PRP, and about 34% of the platelets were 
immobilized onto the GMs by physical absorption. 
Enzyme-linked immunosorbent assay (ELISA) 
We used enzyme-linked immunosorbent assay 
(ELISA) to quantify growth factors' release profiles in 
different groups with the metalloproteinase-3 
(TIMP-3) and IL-10 ELISA Kits (R&D Systems, 
Minneapolis, MN). We tested specimens strictly based 
on the manufacturer’s instructions. The GMs were 
incubated with PRP for 1h, then the mixture was 
washed off with phosphate-buffered saline (PBS) to 
remove any unattached platelets. In order to fully 
activate the platelets, 4% CaCl2 (CaCl2: PRP = 7:1) was 
added into the buffer. Then, we added PBS solution to 
the samples and incubated them at 37 °C. Next, we 
collected the supernatants. This protocol was used for 
the pure PRP group and GM+PRP group. 
Cell isolation and culture 
The skin sample was sliced into 1-2 mm2 of small 
parts that are devoid of hair and fat, which was then 
digested to isolate the cells using trypsin- 
ethylenediaminetetraacetic acid (TE, Mediatech, 
Herndon, VA, USA) and collagenase type I 
(Worthington, Lakewood, NJ, USA). The medium, 
composed of Ham’s Dulbecco’s modified Eagle’s 
medium (DMEM): F12: Epilife (1:1:2; Gibco, 
Invitrogen, Grand Island, NY, USA), was used to 
culture the collected cells, and was replenished by 
fetal bovine serum (5%, FBS, PAA Laboratories, 
Pasching, Austria). In addition, Epilife medium was 
used for culturing keratinocytes. 
Transwell invasion and migration assay 
Millipore Transwell chambers (pore size: 8 μm) 
was used to perform Matrigel invasion assay. We 
combined 500 μL of medium containing 15% FBS with 
100 μL and added the mixture into the lower chamber 
of a 12-well plate to induce cell migration [43]. Cells 
were treated with PBS (control), GM (1 g/L GMs), 
PRP (1 g/L PRP), and GM+PRP (4 g/L GM+PRP). We 
added 2×104 keratinocytes coated with growth-factor 
reduced Matrigel (Corning), and serum-free medium 
(500 μL) into the upper chamber of the plate. The plate 
was incubated for 24 h at 37◦C. The upper surface of 
the membrane of cells was cleaned up using a cotton 
swab before incubation was over. After migration, the 
cells were treated with methanol (Merck) through the 
lower surface of the membrane and stained with 
Giemsa (HiMedia). The images of cells were obtained 
using an inverted microscope (CKX41, Olympus; 
Shinjuku, Tokyo, Japan). NIH ImageJ software 
(dVersion 1.46, Bethesda, MA, USA) was used to 
count the cells in five fields-of-view. The experiment 
was conducted in triplicate. 
Measurement for cell proliferation 
The cytotoxicity of materials to keratinocytes 
was tested by Dojindo Cell Count Kit-8 (CCK-8; 
Kumamoto Techno Research Park, Tokyo, Japan). 
Cells were implanted in 96-well plates with 3×103 cells 
for each well; treated with GM (1 g/L GMs), PRP (1 
g/L PRP), and GM+PRP (4 g/L GM+PRP) [43]; and 
incubated under different lengths of time after 
adhesion (1, 3, 6, 12, 24 and 48 h). After replacing the 
culture media (100 μL DMEM), the plates were 
incubated for 2 h, and then 10 μL of CCK-8 was 
added. To calculate the relative growth rate (RGR), a 
microplate reader (Bio-Rad, Hercules, CA, USA) was 
used to examine optical density (OD) from the 
absorbance at 450 nm. The data were input into the 
computer software for calculation based on RGR = 
testing OD/controlled OD. The blank group of ASCs 
plus PBS was used as the standard, and the cell 
viability calculated by other groups was compared. 
Wound healing model 
A rat excisional wound healing model was used 
to assess the ability of the stromal GM+PRP for 
enhancing wound healing. We set a light-dark cycle of 
12 h, and provided food and water to the rats (female 
Sprague-Dawley, 6-8 weeks old, n = 40), which were 
individually treated. Articaine (0.2 mg/kg body 
weight, hypodermic injection) was used for 
subdermal anesthesia before the operation. Punch 
biopsy was used to create wound of diameter 3 mm 
on the skin on the back of the rats. Body temperature 
was maintained throughout the operation using a 
heating cushion. Erythromycin eye ointment was 
administrated to protect the cornea from drying. The 
40 rats were divided equally into four groups: 
Control, GM, PRP, and GM+PRP. As a control, 0.2 mL 
PBS was injected into the rats. The GM group was 
given 10 mg of GM suspended in PBS (0.2 mL). The 
PRP group was treated with PRP injection (0.2 mL). 
The GM+PRP group was treated with 10 mg GM+PRP 
suspended in PBS (0.2 mL). All injections were 
performed subdermally into the four different 




quadrants of the wound. Until the wound heals or 
reaches day 21, the wound was wrapped daily by 
Tegaderm sterile dressing (3M Healthcare, St Paul, 
Minn.) without interruption. The photos were taken at 
4 different time points during, and at 3, 7, 14, 21 days 
after the operation. ImageJ software was used to 
quantify wound proportions. 
Histological and immunohistological 
assessment 
Hematoxylin & Eosin (HE Stain) was used for 
histological analysis and each harvested specimen 
was analyzed at 3, 7, 14 and 21 days. Masson staining 
was also used to evaluate the density of collagen in 
the wounded skin according to the manufacturer’s 
protocol. Hoechst 33342 was used to stain the nuclei 
(dilution 1:500, Thermo Fisher Scientific, ON, 
Canada). Immunohistochemistry was carried out on 
day 21 after modeling. The main antibody evaluation 
was implemented through mouse monoclonal F4/80 
(dilution 1:200, Abcam, ON, Canada), and 3, 
3’-diaminobenzidine (DAB) was used to visualize the 
target protein. Images were captured using Nikon 90i 
microscope. 
Western blot 
Skin tissues were lysed in radioimmuno-
precipitation assay (RIPA) buffer on ice for 30 min. 
We measured protein expression from the cell lysate 
(30∼60 mg) using IL-6 (ab6672, Abcam, MA, USA), 
IL-10 (12163, CST, MA, USA), VEGF (ab32152, Abcam, 
MA, USA), MCP-1 (ab25124, Abcam, MA, USA), and 
β–actin (3700, CST, MA, USA). Briefly, the samples 
were loaded onto 15% SDS gel to separate the proteins 
by polyacrylamide gel electrophoresis. Then the 
proteins were transferred onto the PDVF membrane 
(ISEQ00010, Millipore, MA, USA). Primary antibodies 
were incubated for 12 h at 4 °C. Washed membrane 
and then incubated it with the HRP-conjugated 
antibody, and finally conducted with ECL. The gray 
value of the bands was analyzed using a gel analyzer 
(Media Cybernetics, MD, USA). 
Statistical analysis 
Data were analyzed by one-way ANOVA with 
Bonferroni post-hoc power analysis. For the wound 
healing analysis, data were analyzed by a two-way 
ANOVA with Bonferroni post-hoc analysis. Statistical 
significance between two or more groups was 
determined by Bonferroni/Dunn’s test. Statistical 
analysis was conducted by Graphpad Prism 7.0 
(Graphpad Software Inc., San Diego, CA, USA), and 
all data shall be expressed in the form of mean ± 
standard error. Significance level was set at P < 0.05. 
Results 
Morphology of GMs and GM+PRP 
Schematic illustration of GMs loaded with PRP is 
presented in Figure 1A. As shown by SEM images, 
numerous platelets were stabilized on the GM surface 
and some platelets were activated (Figure 1B, C). The 
diameter of the GM was 32.02±5.01 µm. 
GM+PRP enhanced and prolonged release 
profile 
The GM+PRP group had prolonged and higher 
release profile compared with the PRP group. IL-10 
level in the GM+PRP group detectable for up to 100 h 
but it was undetectable in the PRP group after 100 h. 
After 24 h, IL-10 level in 
GM+PRP group was 
markedly higher than that 
in PRP group (*P <0.05) 
(Figure 2A). TIMP-3 levels 
followed a similar trend 
as the IL-10 levels. After 
24 h, TIMP-3 level was 
markedly higher in 
GM+PRP group than that 





ability of keratinocytes 
Migratory properties 
of keratinocytes play an 
essential role in wound 
healing. We compared the 
 
 
Figure 1. Schematic illustration. (A) GMs loading with PRP. (B) SEM on GMs with smooth spherical surface. (C) Immobilized PRP 
on GMs. 




four groups to investigate the effect of PRP on 
keratinocyte migration (Figure 2C). There was a 
significant increase in the migration of keratinocytes 
after PRP and GM+PRP treatment (*P < 0.05, 
respectively). There was a statistically significant (*P < 
0.05) difference between GM+PRP group and PRP 
group, while the comparison between control group 
and GM group showed no significant (P > 0.05) 
difference (Figure 2D). CCK8 proliferation assay 
showed that PRP increased cell proliferation more 
than the GM group did, and cell proliferation in the 
GM+PRP group was higher than that in the PRP 
group (Figure 2E). 
GM+PRP promoted wound healing 
After wound creation, each wound randomly 
received one of the four treatments: GM+PRP, PRP, 
GM or PBS. Compared with the control group (P > 
0.05) and the group treated with the stromal vascular 
fraction cell suspension, there were no apparent 
improvement in wound size in the treated group with 
GM+PRP in the early phase of repair (0-3 days). 
However, the wound size in the GM+PRP group was 
smaller than that in the other groups (*P < 0.05) from 
day 3 to 14. Also, a complete wound healing was 
observed in the GM+PRP group at day 14. In contrast 
the other groups did not show complete wound 
closure at day 14 (Figure 3). 
 
 
Figure 2. Effect of GM+PRP on release profile migratory properties of keratinocytes. (A) Release profile for IL-10. (B) Release profile for TIMP-3. (C) Transwell invasion 
migration assay. (D) Cell number. *P < 0.05. (E) The CCK8 assay used to evaluate the proliferation of keratinocytes after incubating with GM, PRP and GM+PRP. One-way 
ANOVA by LSD post hoc. *P < 0.05 compared with the GM group, #P < 0.05 compared with the PRP group. 
 
Figure 3. Treatment influences of GM+PRP, PRP and GM in wound healing. (A) Representative wound pictures on day 3, 7, 14, and 21 after surgery. (B) Percentage of wound 
area observable each day. *P < 0.05 compared to the control (Con) group, #P < 0.05 compared to the PRP group at the same time point. 





Figure 4. Effect of GM+PRP on collagen density and enhanced angiogenesis. (A) Hematoxylin & eosin staining of wounds on day 21 (upper) and Masson staining of wounds on 
day 21 (below). (B) Western-blot analysis of VEGF in wounds. (C) Quantification of blood vessels in wounds. (D) Statistic analysis of VEGF protein in each group wounds. (E) 
qRT-PCR analysis of VEGF in wounds. *P < 0.05. 
 
GM+PRP increased collagen density and 
enhanced angiogenesis 
Re-epithelialization in all the wounds was 
observed on day 21 based on histological analysis. 
Particularly, skin appendage regeneration, and tight 
connection between dermis and epidermis were 
observed in the GM+PRP group. However, skin 
appendage regeneration and loose connection 
between the dermis and epidermis were found in 
other groups (Figure 4A). Collagen density of the 
wounded skin was evaluated by Masson’s trichrome 
staining and the results showed that both GM+PRP 
and PRP increased collagen density in the dermal 




layer of the healing wound, while the GM group and 
the control group shared no difference in collagen 
density (Figure 4A). Blood vessels were counted in 
HE stain, and the results showed that tube-structure 
blood vessels in the GM+PRP group were higher than 
those in the other groups (Figure 4C). Protein level 
(Figure 4B) and gene level of VEGF expression (Figure 
4D, E) in the wound were evaluated; the results 
showed that GM+PRP treatment significantly 
increased the protein level and gene expression of 
VEGF. 
GM+PRP increased local inflammation in the 
wound 
Immunochemistry of F4/80 showed that both 
GM+PRP and PRP increased local macrophage 
infiltration in the dermal layer (Figure 5A). The 
expression of the inflammatory cytokines IL-6, IL-10, 
and MCP-1 by Western blot is shown in Figure 5B. On 
day 7, protein level of MCP-1 was markedly increased 
in the groups of GM+PRP and PRP compared to the 
control group (Figure 5C). Moreover, the GM+PRP 
group had significantly higher-level expression of 
IL-6 compared to that of the PRP group (Figure 5C). 
On day 7, GM+PRP significantly increased IL-10 
expression in GM+PRP group (Figure 5C). Similar 
trend was also demonstrated by the Western blot test 
(Figure 5D).  
Discussion 
It remains a challenge to develop new efficient 
approaches for therapy based on the wound healing 
mechanism and regenerative medicine. Due to 
diabetes and other conditions, it is necessary to 
resolve chronic wounds with new effective therapies. 
Topical application of growth factors that promote 
wound healing is one potential alternative. PRP – an 
autologous agent enriched with high concentration of 
platelets and various growth factors – is regarded as a 
promising therapeutic option to enhance the wound 
healing process [44]. The earlier preparation of PRP 
can go back to the 1970s [45]. However, reliable ways 
to ensure the sustained release of growth factors and 
enhance the long-term therapeutic effect are required 
 
 
Figure 5. Effect of GM+PRP on local inflammation in the wound. (A) Immunochemistry of F4/80 in wounds. (B) Western-blot analysis of inflammation-related cytokines 
expression in wounds. (C) Band density. (D) qRT-PCR analysis. *P < 0.05. 




for further clinical application of PRP [46, 47]. In this 
study, GMs were loaded with PRP to fabricate 
biomimetic bioreactor gelatin microspheres 
(GM+PRP). We then measured its efficacy in treating 
full thickness wound. GM+PRP ensured prolonged 
growth factor VEGF release and improved full 
thickness wound in rats. Platelets and functional 
proteins from the PRP were immobilized onto GMs. 
Our findings suggest that GM+PRP enhances the 
wound healing rate and reduce the wound healing 
time by increasing macrophage infiltration and 
inflammatory cytokines. Our results indicate that 
GMs is an injectable carrier that enhanced the 
therapeutic effect of PRP. 
Our study confirmed that the mRNA and 
protein expression levels of VEGF in the wound were 
up-regulated (p<0.05), indicating that GM+PRP 
induced the transcription and expression of 
endogenous VEGF. GM+PRP significantly increased 
the area containing new capillaries and promoted the 
formation of microvascular network in the 
subcutaneous tissue (Figure 4). Another study has 
shown that PRP with gelatin hydrogel granules 
significantly enlarged the area containing newly 
formed capillaries, and promoted the microvascular 
network in murine subcutaneous tissue [41], thus the 
full-thickness wound in rats was improved. The PRP 
components contain VEGF, IL-10, TIMP-3, TGF-β1, 
PDGF, insulin-like growth factor (IGF)-1, and 
stromal-cell derived factors (SDF-1) [5, 6, 13] .These 
proteins are key in wound healing, as shown by the 
beneficial role of exogenous growth factors in wound 
healing, and in vitro activity of many growth factors 
and cytokines [2, 48]. One study presented that PRP in 
association with insulin regulated Akt mechanism 
and mTOR signalling [9, 24]. Platelets are actively 
involved in biological processes such as tissue 
regeneration and inflammation [49-51]. The 
phenomena are mediated by the storage of 
alpha-granule particles that release platelets including 
extracellular matrix modulators, growth factors, and 
cytokines [23, 49]. Those cytokines and secretory 
proteins could contribute to the healing process by 
different mechanisms. In clinic, the effect of gelatin 
sheet combined with PRP has been reported [33]; the 
surface area of GMs increased, thus, more PRP could 
be immobilized onto the GMs. Furthermore, the sheet 
could sustain the release of factors, and the sheet 
impregnated with factors promoted wound closure 
[36]. In this study, as the surface area of GM increases, 
more PRP could be immobilized onto the GMs, 
stimulating neo-epithelialization and 
neovascularization in murine skin defects. The type A 
gelatin has a positive charge at physiological pH due 
to an isoelectric point of 5 [29, 33]. Once a basic 
growth factor was ionically immobilized in the acidic 
gelatin hydrogel, which can be controlled by 
biodegradation of the biodegraded hydrogel [52]. 
Another study showed that the isoelectric point of 
GMs affected the release rate of growth factors 
adsorbed on the microspheres, and the degradation 
rate of GMs played a decisive role in the release rate of 
growth factors adsorbed on the microspheres [34]. 
Thus, more PRP could be immobilized onto the GMs, 
which ensured prolonged release of VEGF thereby 
up-regulating the mRNA and protein expression 
levels. 
In this study, compared with PRP alone, 
GM+PRP prolonged and enhanced cytokine release 
profile, and showed greater healing potential in acute 
wound. If there is no stabilizer, PRP will immediately 
secrete growth factors after exposure to the activator, 
and the released growth factors will rapidly 
disseminate in the surrounding environment, which 
compromises its long-term effect [53-55]. The release 
profile in GM+PRP group was more prolonged and 
higher compared with the PRP group (Figure 2). 
Platelets on the microspheres’ surface released a 
portion of the growth factors, which were loaded by a 
carrier of gelatin through a physical interfacial 
interaction. From SEM results, it is observed that 
platelets attached to the microspheres’ surface layer 
by layer [56]. The crowded platelet in a layer-by-layer 
structure hindered the activation of platelets, thus, 
prolonging the activation of platelets and causing 
higher and prolonged release of functional proteins 
from the platelets. It is found that hydrogel with 
two/three-dimensional structure is a good carrier to 
deliver the PRP to wound sites, hydrogel works as a 
scaffold or vehicle, and PRP can loaded in hydrogel as 
the two main forms, e.g., PRP gel [11, 57, 58] and 
hydrogel microsphere [36-38]. PRP can be 
incorporated in hydrogel (like gelatin, chitosan, 
collagen and alginate) as a gel, which is a semi-solid 
state. While the introduction of hydrogel 
microspheres such as GMs have been given in the 
above descriptions of this study. Compared with gels, 
hydrogel microspheres like GMs have better 
mechanical properties, and can provide a 3D 
micro-environment for cells growth [59]. 
In this study, we found an immune-regulatory 
function of PRP that improved wound healing 
process (Figure 4). Both PRP and GM+PRP increased 
macrophage infiltration and upregulated 
inflammatory cytokines, and ultimately contributed 
to accelerating wound healing [60]. The recovery of 
damaged connective tissues can be improved by 
activation, migration, and proliferation of fibroblasts. 
The synergetic action of these factors - by inducing 
migration, differentiation, proliferation, and 




stabilization of endothelial cells in new blood vessels - 
sequentially regulate inflammation levels and 
enhance revascularization of damaged tissues. 
Moreover, it can increase stem cell recruitment, 
differentiation, and proliferation to tissue-specific cell 
types [61]. 
It is crucial to eliminate devitalized tissues and 
cellular debris and to avoid infection through immune 
and inflammatory pathways. Wound healing is a 
physiological and dynamic process that involves 
sequential stages of acute inflammation, formation 
and proliferation of new tissues, and remodeling to 
restore the regular structure and function of the 
damaged tissues [6]. After tissue damage, wound 
repair instantly takes place to form platelet embolism, 
and then a fibrin matrix is consolidated to turn into a 
scaffold for cell attachment. Monocytes differentiate 
into M1 macrophage phenotype after recruitments of 
monocytes and neutrophils [62]. 
In the current study, both GM+PRP and PRP 
increased macrophage infiltration on day 7. MCP-1 
has a vital function in the site of inflammation to 
recruit mononuclear cells [63] and was significantly 
enhanced in the GM+PRP and PRP groups [42, 64]. 
MCP-1 expression could be transiently induced by 
platelet-derived products, such as serotonin, 
PDGF-BB, or PDGF-AB [65]. Moreover, pro-inflam-
matory cytokines (e.g., IL-6) were also significantly 
increased in the GM+PRP group, indicating that 
inflammatory cells were highly active during this 
period to remove cellular debris and stimulate 
angiogenesis, providing a favorable environment for 
tissue regeneration. 
Mesenchymal cells, endothelial cells, granulo-
cytes, fibroblasts, and macrophages can synthesize 
and release growth factors after obtaining a stimulus 
from platelets [66]. Anti-inflammatory cytokines were 
significantly upregulated in the GM+PRP group. 
High levels of anti-inflammatory cytokines play an 
important role in transforming pro-inflammatory 
phase and transitioning to regeneration phase. The 
GM+PRP group had both active pro-inflammatory 
and anti-inflammatory phases. Due to the 
dysregulation, complex diseases may be exacerbated 
and may even prevent repair; thus, rapid 
pre-inflammatory phase and transition to 
regeneration phase are critical to damaged tissues [48, 
67, 68]. However, as with many tissue-engineered 
skin substitutes, the risk of immune rejection between 
gelatin and biological tissues is unavoidable, and the 
process of injecting PRP into GMs is extremely 
time-consuming. 
Conclusion 
GM+PRP prolonged and enhanced cytokine 
release profile compared with PRP, thus showing 
greater healing potential in acute wound. GM+PRP 
may have the potential to accelerate the wound 
healing process by increasing macrophage infiltration 
and upregulating inflammatory cytokines. These 
findings indicate that an injectable carrier, GM, 
enhanced the therapeutic effect of PRP. 
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